Tag: multiple myeloma
GSK’s blood cancer drug gets EU approval
<!--><!--><!--><!--> Multiple myeloma is the third most common blood cancer globally and is generally considered treatable but not curable. It affects the immunity-boosting plasma white ... Read More
US FDA approves Regeneron’s blood cancer therapy
<!--><!--><!--><!--> Over 36,000 new cases of multiple myeloma are estimated to be diagnosed in the U.S. in 2025, according to the American Cancer Society |Image ... Read More